Skip to main content

Innovex International, Inc.

For the period ended Mar 31, 2025. Filed May 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

INVX$25.13+2.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)March 31,2025December 31,2024
Assets
Current assets
Cash and restricted cash$68,116$73,278
Trade receivables, net of allowance of $57,632 and $63,875 at March 31, 2025 and December 31, 2024, respectively236,020239,506
Contract assets5,5125,062
Inventories269,251271,173
Assets held for sale5,7604,749
Prepaid expenses and other current assets47,97947,623
Total current assets632,638641,391
Noncurrent assets
Property and equipment, net188,426190,786
Right of use assets – operating56,96054,873
Goodwill75,56860,176
Intangibles, net104,746108,363
Deferred tax asset, net128,992134,540
Other long-term assets8,6737,354
Total noncurrent assets563,365556,092
Total assets$1,196,003$1,197,483
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$76,391$65,201
Operating lease liabilities11,53510,547
Accrued expenses37,11660,593
Contract liabilities11,12813,463
Current portion of long-term debt and finance lease obligations5,55610,467
Other current liabilities4,0932,387
Total current liabilities145,819162,658
Noncurrent liabilities
Long-term debt and finance lease obligations19,67924,901
Operating lease liabilities45,96245,153
Deferred income taxes726624
Other long-term liabilities5,4415,991
Total noncurrent liabilities71,80876,669
Total liabilities$217,627$239,327
Commitments and contingencies (Note 16)
Stockholders’ equity
Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)$—$—
Common stock: $0.01 par value, 100,000,000 shares authorized at March 31, 2025 and December 31, 2024; 69,337,922 and 69,178,263 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively693692
Additional paid-in capital756,548755,077
Accumulated other comprehensive income(4,247)(8,863)
Retained earnings225,382211,250
Total stockholders’ equity$978,376$958,156
Total liabilities and stockholders’ equity$1,196,003$1,197,483
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.